FDA Adverse Event Death Summary report: N

SYNERGY XD

MDR report key: 18387773 · Received December 22, 2023

Report

Report Number
2124215-2023-69614
Event Type
Death
Date Received
December 22, 2023
Date of Event
December 4, 2023
Report Date
December 22, 2023
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
NIQ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT DIED. THE PATIENT PRESENTED WITH CO-MORBIDITIES OF EXTREMELY CALCIFIED VESSELS. THE LESION BEING TREATED WAS THE LEFT ANTERIOR DESCENDING (LAD) ARTERY. AN OPTICROSS INTRAVASCULAR ULTRASOUND (IVUS) IMAGING WAS UTILIZED TO ENSURE THE CORRECT SIZING AND STRATEGY IN APPROACHING TREATMENT OF THE LESION. FOLLOWING ORBITAL ATHERECTOMY TO PREPARE THE SEVERELY CALCIFIED VESSEL, IVUS IMAGING WAS PERFORMED FOLLOWED BY A 10MM X 2.5MM WOLVERINE CUTTING BALLOON CATHETER TO FURTHER PREPARE THE VESSEL PRIOR STENTING THE LAD. A 3.00 X 24MM AND A 2.50 X 28MM SYNERGY XD DRUG-ELUTING STENTS WERE DEPLOYED IN THE PROXIMAL AND MID LAD SUCCESSFULLY. POST-DILATATION WAS THEN PERFORMED USING A 3.00MM X 15MM AND A 2.50MM X 12MM NC EMERGE BALLOON CATHETERS. AFTER A SECOND RUN OF IVUS IMAGING AND CONFIRMATION OF STENT EXPANSION, THE PROCEDURE WAS DEEMED SUCCESSFULLY COMPLETED. AFTER THE PROCEDURE, THE PATIENT STATUS WAS INITIALLY GOOD, AND THE PATIENT WAS TAKEN BACK TO THE RECOVERY WARD. HOWEVER, 15 MINUTES LATER, THE PATIENT'S HEALTH DECLINED AND WAS BROUGHT BACK TO THE PROCEDURE ROOM TO INVESTIGATE THE CAUSE. AN ATTEMPT TO RE-WIRE THE ORIGINAL LESION WAS UNSUCCESSFUL AS THE PATIENT HEALTH CONTINUED TO DECLINE. THE PATIENT CRASHED AND CARDIOPULMONARY RESUSCITATION (CPR) WAS PERFORMED, HOWEVER UNSUCCESSFUL, AND THE PATIENT PASSED AWAY. THE OFFICIAL CAUSE OF DEATH WAS POST-PROCEDURAL COMPLICATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1609482 SYNERGY XD CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC CORPORATION 0030247309

Patients

Seq Age Sex Outcome Treatment
1 Female Death